Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
ono-7475 tyrosine-protein kinase ufo NA Successful target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Leukemia
Myelocytic
Acute[MeSHID:D015470]		 NA phase 1/2 unknown
ono-7475 tyrosine-protein kinase ufo NA Successful target TTD , DGIDB MYELODYSPLASTIC SYNDROME[MeSHID:D009190]
leukemia[MeSHID:D007938]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA phase 1 unknown
ono-7475 tyrosine-protein kinase ufo NA Successful target TTD , DGIDB MYELODYSPLASTIC SYNDROME[MeSHID:D009190]
leukemia[MeSHID:D007938]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA phase 1/2 unknown
ono-7475 tyrosine-protein kinase ufo NA Successful target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Leukemia
Myelocytic
Acute[MeSHID:D015470]		 NA phase 1 unknown
ono-7475 tyrosine-protein kinase mer NA Clinical trial target TTD , DGIDB MYELODYSPLASTIC SYNDROME[MeSHID:D009190]
leukemia[MeSHID:D007938]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA phase 1/2 unknown
ono-7475 tyrosine-protein kinase mer NA Clinical trial target TTD , DGIDB MYELODYSPLASTIC SYNDROME[MeSHID:D009190]
leukemia[MeSHID:D007938]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA phase 1 unknown
ono-7475 tyrosine-protein kinase mer NA Clinical trial target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Leukemia
Myelocytic
Acute[MeSHID:D015470]		 NA phase 1 unknown
ono-7475 tyrosine-protein kinase mer NA Clinical trial target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Leukemia
Myelocytic
Acute[MeSHID:D015470]		 NA phase 1/2 unknown
click here to return to the previous page